Hamilton, D. O., Main-Ian, A., Tebbutt, J., Thrasher, M., Waite, A., & Welters, I. (2021). Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19. BMC.
Style de citation Chicago (17e éd.)Hamilton, David Oliver, Alexander Main-Ian, Jessie Tebbutt, Maya Thrasher, Alicia Waite, et Ingeborg Welters. Standard- Versus Intermediate-dose Enoxaparin for Anti-factor Xa Guided Thromboprophylaxis in Critically Ill Patients with COVID-19. BMC, 2021.
Style de citation MLA (8e éd.)Hamilton, David Oliver, et al. Standard- Versus Intermediate-dose Enoxaparin for Anti-factor Xa Guided Thromboprophylaxis in Critically Ill Patients with COVID-19. BMC, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.